HIND: Vyome Holdings Inc. Kompaniya qiymatining sof foydaga nisbati

Vyome Therapeutics - HIND emitenti grafik logotipi

Vyome Holdings Inc (HIND) dori vositalarini ishlab chiqishni tezlashtirish uchun avtomatlashtirilgan klinik ma'lumotlar tahlili tizimlari va robotlashtirilgan molekulalarni skrining qilish texnologiyalarini joriy qilmoqda. Kompaniya og'ir teri patologiyalari uchun xavfsiz terapiya usullarini yaratganligi uchun ilmiy tan olinishga sazovor bo'ldi. Joriy PE koeffitsiyenti -2.90 ni tashkil etadi. Foyda o'sishi potentsiali, quyidagi grafikda ko'rsatilgan narxlar dinamikasi bilan tasdiqlanganidek, hamkorlar orqali ishlab chiqarishni kengaytirish bilan bog'liq.

Vyome Holdings (HIND) Narxning foydaga nisbati: 16.08.2025 - 18.11.2026 davri uchun

Vyome Therapeutics (HIND) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:Vyome Holdings HIND
ReShape Lifesciences brend mahsuloti

Vyome Holdings Inc (HIND) o'zining bozor imidji va aktivlar tuzilmasiga tegishli chuqur yangilanish bosqichidan o'tmoqda. Kompaniyaning fundamental P/E koeffitsiyenti dinamikasi ushbu transformatsiyaga nisbatan investorlar ishonchining joriy darajasini aks ettiradi. Ushbu metrika bozor kapitalizatsiyasining sof foydaga nisbati sifatida hisoblanadi va investitsiya qilingan kapitalning qoplash muddatini o'lchaydi. Grafikdagi yuqori qiymatlar kelajakdagi daromadlar bo'yicha bozor kutganlarining ortiqcha ekanligidan dalolat beradi. "Kutib qolish va kuzatish" obro'sini hisobga olgan holda, ushbu ko'rsatkich biznesning pragmatik baholanishi uchun asosiy o'lchovga aylanadi.

Muhim raqobatchilar

P/E multiplikatori Argenx|Narx-foyda koeffitsiyenti BNTX (BioNTech Group)|ABVX (abivax.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (admabiologics.com)|Biznesning o‘zini qoplash muddati protagonist-inc.com (PTGX)|IMVT - Narxning foydaga nisbati|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Narx-foyda koeffitsiyenti|Grifols Biemat (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotechnologies|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori auriniapharma.com|Narxning foydaga nisbati BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Narx-foyda multiplikatori|P/E multiplikatori DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Biologics - P/E multiplikatori|tourmalinebio.com - Bozor narxining sof foydaga nisbati|Precigen (PGEN) - Narxning foydaga nisbati|Pharming Group - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Nektar Therapeutics Inc|UPB (Upstream Pharma) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ZBIO|P/E multiplikatori immunome.com (IMNM)|P/E multiplikatori GOSS (gossamerbio.com)|Biznesning o‘zini qoplash muddati KalVista Pharma (KALV)|SEPN - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - P/E multiplikatori|ATXS (Astria Therapeutics, Inc.) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ACRS|Kyverna Therapeutics, Inc - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati TLSA|CABA: P/E multiplikatori|Narx-foyda koeffitsiyenti Ventyx Bio|Narxning foydaga nisbati Theratechnologies, Inc.|Kapitalizatsiyaning foydaga nisbati Avalo Therapeutics AVTX|P/E multiplikatori ELDN|AGEN (Agenus, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Kapitalizatsiyaning foydaga nisbati|ATYR: Narx-foyda koeffitsiyenti|adagene.com (ADAG) - Narx-foyda koeffitsiyenti|Ikena Oncology (IMA) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Shattuck Labs, Inc.|Narxning foydaga nisbati equilliumbio.com|Narx-foyda koeffitsiyenti connectbiopharm.com (CNTB)|P/E multiplikatori IMUX|Biznesning o‘zini qoplash muddati Atara Bio|Narxning foydaga nisbati InflaRx N.V. IFRX|X4 Pharmaceuticals - Narxning foydaga nisbati|ACET: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CELU (celularity.com)|INMB: P/E multiplikatori|BRNS: Bozor narxining sof foydaga nisbati|KZR (Kezar Life Sciences, Inc.) - P/E multiplikatori|SAB Biotherapeutics Inc. (SABS) - Biznesning o‘zini qoplash muddati|P/E multiplikatori AKTX|Narxning foydaga nisbati ENLV (Enlivex Therapeutics Ltd)|Narxning foydaga nisbati Q32 Bio Inc. QTTB|GOVX - Narx-foyda koeffitsiyenti|EDSA - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati iBio|CARM: P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati XTLB (XTL Biopharmaceuticals, Ltd.)|Narxning foydaga nisbati boltbio.com|P/E multiplikatori HCW Biologics|P/E multiplikatori APVO|AIM - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ADTX (Aditxt Inc.)|Biznesning o‘zini qoplash muddati GRI Bio, Inc. (GRI)|XRTX - Narxning foydaga nisbati|Revelation Biosciences (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Scinai Immunotherapeutics Ltd (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|affimed.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati allakos.com (ALLK)|P/E multiplikatori HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Narx-foyda koeffitsiyenti|iTeos Therapeutics, Inc. (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) PLC)|THRD: P/E multiplikatori